Professor KIM Sung Hoon
Professor Sung Hoon Kim (Department of Molecular Medicine and Biopharmaceutical Sciences) has received the 2015 Hoam Award in Medicine for his contributions to greater understanding of aminoacyl-tRNA synthetase. Professor Kim first started researching aminoacyl-tRNA in 1994 when he returned to Korea after his postdoc at MIT. Since then, Professor Kim has discovered that aminoacyl-tRNA deters cancer and is involved in differentiation. He also discovered that KRS, an enzyme involved in synthesizing lysine and tRNA, is responsible for cancer metastasis and found a material which deters the process. Professor Kim co-founded Cubist Pharmaceuticals, the company responsible for the sale of tedizolid phosphate (Sivextro). “I am happy that basic science research can lead to saving more lives,” said Professor Kim.
- 2015 Hoam Awards: http://hoamprize.samsungfoundation.org/
- Professors KIM Sung Hoon: http://mmbs.snu.ac.kr/Faculty/FacultyView.asp?mem_idx=14
- SNU Department of Molecular Medicine and Biopharmaceutical Sciences: http://mmbs.snu.ac.kr/
Summary by LEE HeeUn, SNU English Editor, gurume0221@snu.ac.kr
Proofread by Melora Brett Briana Johnson, morningcalm2@gmail.com